KTTA - Pasithea Therapeutics Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Pasithea Therapeutics Corp's activity chart (see below) currently has 2 price targets and 3 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 338 days.

Most recent stock forecast was given by ELEMER PIROS from BENCHMARK on 10-Jul-2023. First documented stock forecast 15-Dec-2021.

Constantine Davides Elemer Piros

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$-3.06 (-60.47%)

Buy Since 15-Dec-2021

$0.81 (68.07%)

$65

Show more analysts

What is KTTA (Pasithea Therapeutics Corp) average time for price targets to be met?

On average it took 338 days on average for the stock forecasts to be realized with a an average price target met ratio 25

Which analyst has the current highest performing score on KTTA (Pasithea Therapeutics Corp) with a proven track record?

CONSTANTINE DAVIDES

Which analyst has the current lower performing score on KTTA (Pasithea Therapeutics Corp) with a proven track record?

ELEMER PIROS

Which analyst has the most public recommendations on KTTA (Pasithea Therapeutics Corp)?

Constantine Davides has 7 price targets and 5 ratings on KTTA

Which analyst is the currently most bullish on KTTA (Pasithea Therapeutics Corp)?

Constantine Davides with highest potential upside - $0.81

Which analyst is the currently most reserved on KTTA (Pasithea Therapeutics Corp)?

Elemer Piros with lowest potential downside - -$3.06